Brind.

Baxter maintained its U.S. production levels for IV fluids in July 2025.

1 report, 1 independent Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Baxter maintained its U.S. production levels for IV fluids in July 2025.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Baxter hosted a conference call from Deerfield on July 18, 2025, with Kate Durham serving as media contact.Sub-event
  2. Baxter confirmed stable production levels for its IV fluids in the U.S.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireVizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter IRVING, Texas, July 23, 2025--(BUSINESS WIRE)--Vizient® announced today the expansion of the Vizient